Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAQR9 antisense RNA 1 (PAQR9-AS1) is a long non-coding RNA gene located on human chromosome 3. It is transcribed from the DNA strand opposite to the PAQR9 gene, and as an antisense RNA, it may modulate the expression of PAQR9 via RNA-RNA interactions or genomic regulation. There is currently no evidence indicating that PAQR9-AS1 is directly implicated as a therapeutic target, nor are there described functions, disease associations, or drug interactions specific to this lncRNA in the published literature[1][4][6][11][12]. While antisense RNAs as a class can have roles in gene regulation, specific functional annotation for PAQR9-AS1 remains lacking. Note: There may be confusion with PAQR9 (progestin and adipoQ receptor family member 9), a membrane progestin receptor involved in steroid signaling, but PAQR9-AS1 itself is not a receptor or protein-coding gene[3][4][7][10].
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PAQR9 antisense RNA 1 (PAQR9-AS1).